Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program

PARK CITY, Utah, July 30 /PRNewswire-FirstCall/ -- Nutraceutical International Corporation (Nasdaq: NUTR ) today reported results for the fiscal 2009 third quarter ended June 30, 2009. Net sales for the fiscal 2009 third quarter were $39.4 million compared to $40.5 million for t...

Young Innovations, Inc. Board of Directors Declares Quarterly Dividend and Authorizes Share Repurchase Program

ST. LOUIS, July 21 /PRNewswire-FirstCall/ -- Young Innovations, Inc. (Nasdaq: YDNT ) today announced that its Board of Directors declared a quarterly dividend of $0.04 per share, payable September 15, 2009 to all shareholders of record on August 14, 2009. The Board of Directors also au...

Bradmer to repurchase up to 8.3 million of its common shares pursuant to a substantial issuer bid

TSX: BMR TORONTO, July 17 /PRNewswire-FirstCall/ - Bradmer Pharmaceuticals Inc. (TSX: BMR) ("Bradmer" or the "Corporation") announced today that its Board of Directors has authorized the Corporation to proceed with a substantial issuer bid (the "Offer"), pursuant to which the Corporation will...

CorVel Corporation to Adopt 10b5-1 Stock Repurchase Plan

IRVINE, Calif., June 15 /PRNewswire-FirstCall/ -- CorVel Corporation (Nasdaq: CRVL ) announced today that pursuant to Board of Directors approval, the Company entered into a pre-arranged stock trading plan on June 12, 2009, to repurchase shares of its common stock through a brokerage agreement. ...

Valeant Announces Increase to Securities Repurchase Program

ALISO VIEJO, Calif., May 28 /PRNewswire-FirstCall/ -- Valeant Pharmaceuticals International (NYSE: VRX ) announced today that its board of directors has authorized the repurchase of an additional $300 million of its outstanding convertible debt or common stock under the securities repurchase pro...

Dialysis Corporation of America Announces Share Repurchase Program

LINTHICUM, Md., April 13 /PRNewswire-FirstCall/ -- Dialysis Corporation of America (Nasdaq: DCAI ) announced that its Board of Directors has approved a stock repurchase program, effective April 13, 2009. Under the program, the company is authorized to repurchase up to $3 million of its outst...

Kensey Nash Announces 600,000 Share Stock Repurchase Program

EXTON, Pa., March 18 /PRNewswire-FirstCall/ -- Kensey Nash Corporation (Nasdaq: KNSY ) today announced that its board of directors has approved a stock repurchase. The new program allows the Company to repurchase up to a total of 600,000 of its issued and outstanding shares of Common Stock and ...

Neogen Reactivates Share Repurchase Program

LANSING, Mich., March 9 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG ) announced today that on March 6 it initiated its current common stock repurchase program. In December, Neogen's Board of Directors authorized the repurchase of up to 500,000 shares. Shares have been, and ad...

Rochester Medical Renews Share Repurchase Activity

STEWARTVILLE, Minn., March 3 /PRNewswire-FirstCall/ -- Rochester Medical Corporation (Nasdaq: ROCM ) today announced its intention to repurchase some of the company's outstanding common shares pursuant to its previously authorized share repurchase program. The company plans to repurchase shares...

Abbott Announces Required Offer to Repurchase Convertible Senior Subordinated Notes of Its AMO Subsidiary

ABBOTT PARK, Ill., Feb. 27 /PRNewswire-FirstCall/ -- Abbott ( NYSE: ABT ) today announced that, in connection with the consummation of its acquisition of Advanced Medical Optics (now Abbott Medical Optics or AMO) pursuant to a "first step" cash tender offer by a wholly-owned subsidiary of Abbott...

repurchase in Medical Technology

Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status

...l be announced by the end of the third quarter of 2009 AZ-004 and AZ-104 have been licensed to Symphony Allegro, and the Company has the right to repurchase all rights to these product candidates. Conference Call Information Alexza will host a conference call today, May 7, 2009, at 5:30 p.m. Easte...

Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments

...GS also announced that it has repurchased $106.2 million principal amount of its outstanding convertible debt at a cost of $50.0 million in cash. The repurchase includes $82.9 million principal amount of the Company's 2 1/4% Convertible Subordinated Notes Due October 2011, and $23.3 million principal amount of...

American Dairy Provides Business Update

...na's Most Influential Companies - - Announces repurchase of Additional $3.77 Million of Convertible Notes -...tribution to China's agricultural industry. repurchase of an Additional $3.77 Million of Convertible Note...s"), the Company completed the second phase in the repurchase of its outstanding 2012 Notes. As previously anno...

Alexza Reports 2008 Second Quarter Financial Results and Updates Development of Product Candidates

..., or Symphony Allegro, and Alexza has the right to repurchase all rights to this product candidate. -- AZ-001 ...d to Symphony Allegro, and Alexza has the right to repurchase all rights to this product candidate. -- AZ-002 ...d to Symphony Allegro, and Alexza has the right to repurchase all rights to this product candidate. -- AZ-003 ...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

...ctions during the second quarter of 2008 included the sale of the rights to belinostat to TopoTarget A/S for approximately $38 million in cash and the repurchase of $50.9 million of debt for $43.2 million in privately negotiated transactions. As of June 30, 2008, CuraGen had cash, restricted cash and investme...

Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results

...22 Payments on debt (4,356) (2,103) Issuance of common stock and warrants 13,644 45,449 repurchase of restricted common stock - (4) Net cash provided by financing activities 16,172 48,164 Net increase i...

repurchase in Biological Technology

Techne Corporation Declares Dividend and Announces an Increase in Its Share Repurchase Program

MINNEAPOLIS, April 28 /PRNewswire-FirstCall/ -- Techne Corporation (Nasdaq: TECH ) announced that its Board of Directors has decided to pay a dividend of $0.25 per share for the quarter ended March 31, 2009. The quarterly dividend will be payable May 22, 2009 to all common shareholders of recor...

ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes

EXTON, Pa., March 24 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM ) announced it has repurchased, in a privately negotiated transaction, $45 million principal amount or 18 percent of the company's Senior Convertible Notes due March 2017 for total consideration of approximately $21.2 mil...

Osteotech Announces Stock Repurchase Program

EATONTOWN, N.J., Dec. 11 /PRNewswire-FirstCall/ -- Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic products for regenerative healing, announced today that its Board of Directors has authorized a stock repurchase program under which up to $5.0 million of Osteotech's co...

Neogen Announces New Share Repurchase Program

LANSING, Mich., Dec. 11 /PRNewswire-FirstCall/ -- Neogen Corporation (Nasdaq: NEOG ) announced today that its Board of Directors has initiated a new share repurchase program to purchase up to 500,000 shares of the company's common stock. In a joint move, the Board rescinded the previous stock re...

Rosetta Genomics Reports Third Quarter 2008 Financial Results; Records First Revenues of $705,000; $7.4 Million Added to Available Cash Due to Repurchase of ARS

REHOVOT, Israel and JERSEY CITY, New Jersey, December 5 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDAQ: ROSG ), an innovative molecular diagnostic company leveraging microRNAs as biomarkers, reported today its consolidated financial results for the quarter ended September 30, 2008 ...

Aware, Inc. Announces Extension of Stock Repurchase Plan

BEDFORD, Mass., Oct. 29 /PRNewswire-FirstCall/ -- Aware, Inc. (Nasdaq: AWRE), a leading supplier of broadband technology and biometrics software, announced today that its Board of Directors has approved an extension to the program originally authorized on August 28, 2007 to repurchase from tim...

China Yingxia International, Inc. Announces $2 Million Share Repurchase Program

HARBIN, China, Oct. 9 /Xinhua-PRNewswire-FirstCall/ -- China Yingxia International, Inc. (OTC Bulletin Board: CYXI) ("China Yingxia" or "the Company"), a leading provider in the health and nutritional food industry engaged in the development, manufacture and distribution of nutritional food pr...

Exponent Adds $35 Million to Stock Repurchase Program

MENLO PARK, Calif., June 3 /PRNewswire-FirstCall/ -- Exponent, Inc. (Nasdaq: EXPO ) announced today that its Board of Directors has authorized up to an additional $35,000,000 for the repurchase of Exponent's common stock in the open market or privately negotiated transactions in compliance wi...

Align Technology Announces $50 Million Stock Repurchase Program

SANTA CLARA, Calif., April 29 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN ) today announced that its board of directors has authorized a stock repurchase program of up to $50 million, effective immediately. "We are confident in our ability to generate cash in excess of ou...

3SBio Inc. Approves Share Repurchase Program

SHENYANG, China, March 19 /Xinhua-PRNewswire-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX ) ("3SBio" or the "Company"), a leading, fully integrated, biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced today t...